|

XZP-5955 tablets Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Xuanzhu Biopharmaceutical Co., Ltd.1

Indications

  • Locally Advanced or Metastatic Non-small Cell Lung Cancer1
  • Locally Advanced or Metastatic Solid Tumors1
  • Lung Cancer1
  • Cancer1

Other1 trial

A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.